Table 2 Hemodynamic and echocardiographic parameters
| Â | Pre | Post | Mean Difference (95% CI) | p value |
|---|---|---|---|---|
Hemodynamic parameters | ||||
 HR [bpm] | 75 (SD 15) | 66 (SD 14) | −9 (−12 to −5) | < 0.0001 |
 Systolic BP [mmHg] | 136 (SD 24) | 112 (SD 19) | −24 (−32 to − 17) | < 0.0001 |
 Diastolic BP [mmHg] | 70 (IQR 60 to 80) | 57 (SD 11) | −13 (− 18 to −8) | < 0.0001 a |
 Mean BP [mmHg] | 91 (IQR 80 to 104) | 75 (SD 12) | −17 (− 22 to − 12) | < 0.0001 a |
Echocardiographic parameters | ||||
Right ventricle | ||||
RVEDAI (cm2/m2) n = 49 | 13 (SD 3) | 13 (SD 2) | −0.3 (−1 to 0.4) | 0.3585 |
RVEDV (ml) n = 53 | 132 (SD 35) | 132 (SD 36) | −0.0 (−8 to 8) | 0.9996 |
RVESV (ml) n = 53 | 76 (SD 25) | 78 (SD 27) | 2.4 (−3.2 to 8.1) | 0.3923 |
RVEDVI (ml/m2) n = 53 | 67 (SD 17) | 67 (SD 17) | −0.3 (−5.2 to 4.5) | 0.9609 |
RVESVI (ml/m2) n = 53 | 35 (IQR 32 to 44) | 37 (IQR 30 to 45) | 1.1 (−1.8 to 3.9) | 0.4482 |
RVFAC (%) n = 49 | 38 (SD 9) | 38 (SD 9) | −0.3 (−2.4 to 1.8) | 0.7538 |
RVEF (%) n = 53 | 43 (SD 9) | 42 (SD 8) | −1.4 (− 3.5 to 0.6) | 0.1607 |
Stroke Volume (ml) n = 53 | 57 (SD 19) | 54 (SD 16) | −3 (−7.5 to 1.5) | 0.1838 |
TAPSE (mm) n = 51 | 18 (SD 4) | 16 (SD 4) | −1.6 (−2.6 to −0.7) | 0.0013 |
TDI TV s’ (cm/s) n = 43 | 13.2 (IQR 11.8 to 15.9) | 11.8 (IQR 10.1 to 13.3) | −1.9 (−2.6 to − 1.2) | < 0.0001 |
3D-RVLS-fw (%) n = 52 | −22.9 (SD 6) | − 21.4 (SD 5.9) | 1.5 (0.1 to 2.9) | 0.0366 |
3D-RVLS-sw (%) n = 52 | −12.8 (SD 5.2) | − 12.3 (SD 3.9) | −0.3 (− 1.2 to 1.9) | 0.5492 |
Tricuspid valve regurgitation (n=) | Â | |||
 None or trace | 26 | |||
 Mild | 25 | |||
 Moderate | 2 | |||
 Severe | 0 | |||
Left ventricle | ||||
LVEDVI (ml/m2) n = 38 | 80 (SD 24) | 79 (SD 25) | −0.5 (−4.3 to 3.3) | 0.7880 |
3D-LVEF (%) n = 38 | 53 (SD 16) | 52 (SD 13) | −0.9 (−4.1 to 2.3) | 0.5704 |